D. Curtin

发表

Computer-generated STOPP/START recommendations for hospitalised older adults: evaluation of the relationship between clinical relevance and rate of implementation in the SENATOR trial.

D. O’Mahony, K. Dalton, S. Byrne, 2020, Age and ageing.

Identifying Explicit Criteria for the Prevention of Falls

D. O’Mahony, S. Byrne, D. Curtin, 2016 .

Drug consumption and futile medication prescribing in the last year of life: an observational study

P. Gallagher, D. O'mahony, D. Curtin, 2018, Age and ageing.

Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases

P. Gallagher, D. O’Mahony, Kirstyn James, 2018, European Journal of Clinical Pharmacology.

C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism

N. Williams, B. Traynor, H. Morris, 2012, Movement disorders : official journal of the Movement Disorder Society.

Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity

Sei J. Lee, D. Bauer, N. Rodondi, 2022, JAMA network open.

Stroke Subtype Classification to Mechanism-Specific and Undetermined Categories by TOAST, A-S-C-O, and Causative Classification System: Direct Comparison in the North Dublin Population Stroke Study

P. Kelly, E. Williams, L. Kyne, 2010, Stroke.

Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases

P. Gallagher, D. O’Mahony, Kirstyn James, 2018, European Journal of Clinical Pharmacology.

Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences

P. Gallagher, D. O’Mahony, D. Curtin, 2019, Therapeutic advances in drug safety.

Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis

G. Onder, K. Palmer, M. Petrovic, 2018, European Geriatric Medicine.

Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria

P. Gallagher, D. O’Mahony, E. Jennings, 2019, Journal of the American Geriatrics Society.

Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2.

P. Gallagher, D. O’Mahony, D. Curtin, 2019, Age and ageing.

Polypharmacy stewardship: a novel approach to tackle a major public health crisis.

D. O’Mahony, D. Curtin, R. Daunt, 2023, The lancet. Healthy longevity.

Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.

M. Petrovic, R. Fordham, A. Cherubini, 2020, Age and ageing.

C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism

B. Traynor, H. Morris, T. Lynch, 2012, Movement Disorders.

STOPP/START criteria for potentially inappropriate prescribing in older people: version 3

G. Onder, M. Petrovic, N. van der Velde, 2023, European Geriatric Medicine.

STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact.

D. Curtin, Siobhán McGettigan, Denis O’Mahony, 2023, Expert review of clinical pharmacology.

Authors’ response to points raised by Boland et al. regarding STOPP/START version 3 criteria

A. Cruz-Jentoft, W. Knol, J. Beuscart, 2023, European Geriatric Medicine.

Deprescribing in older people: why it matters in routine clinical practice.

D. O’Mahony, D. Curtin, 2018, Polish archives of internal medicine.

Predicting 1‐Year Mortality in Older Hospitalized Patients: External Validation of the HOMR Model

M. van Smeden, P. Gallagher, D. O’Mahony, 2019, Journal of the American Geriatrics Society.

Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention

D. Curtin, Siobhán McGettigan, Denis O’Mahony, 2024, Pharmacoepidemiology.